WHAT IS INTERLYMPH?
The International Lymphoma Epidemiology Consortium (InterLymph) is an open scientific forum for epidemiologic research in lymphoproliferative disorders. Established in 2001, the Consortium is an international group of scientists who undertake research projects that pool data across studies to better understand lymphoma risk factors.
Find out more: http://epi.grants.cancer.gov/InterLymph/
WHAT ARE THE OBJECTIVES OF INTERLYMPH?
The objectives of InterLymph are to expand knowledge of lymphoma causes and survival through:
- Fostering collaborations between researchers in different countries;
- Providing a framework for the efficient conduct and publication of original data meta-analyses of relevant studies;
- Providing a forum and framework for discussion, development and pursuit of new research directions; and
- Supporting the development of early career researchers.
IN WHAT AREAS DOES INTERLYMPH FOCUS ITS WORK?
InterLymph consists of seven working groups.
- Family Working Group
- Hodgkin Lymphoma
- Immunology and Infection,
- Lifestyle and Environment
- Multiple Myeloma
- Pathology and Survival
LEARN MORE ABOUT KEY FINDINGS FROM THE INTERLYMPH SCIENTIFIC MEETINGS.